Is Novavax Stock A Buy On Its Leading Covid Vaccine Effectiveness?

Is Novavax Stock A Buy On Its Leading Covid Vaccine Effectiveness?
ALLISON GATLIN
·7 min read

Novavax said in March its coronavirus vaccine was 96.4% effective in a Phase 3 test. It's also effective against variants. It's now seeking authorization. Is NVAX stock a buy?